Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
34.01 Down 0.56(1.62%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
ReleasedContributorAuthorTitlePagesPrice
Apr 16, 2014Pechala's ReportsLubomir PechalaISIS PHARMACEUTICALS (ISIS) - REPORT FOR ACTIVE TRADERS1$25
Apr 16, 2014ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for ISIS11$25
Apr 16, 2014ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49
Apr 16, 2014New Constructs, LLCN/AISIS: Due Diligence Review: Forensic Earnings and Valuation5$25
Apr 11, 2014Alpha Street ResearchHunter OrrISIS - Isis Pharmaceuticals Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report9$24
Apr 11, 2014S&P Capital IQ Quantitative ReportN/AIsis Pharmaceuticals11$126.50
Apr 11, 2014Pechala's ReportsFrantisek PechalaISIS PHARMACEUTICALS (ISIS) 12-months forecast1$15
Apr 10, 2014Ford Investor Services, Inc.N/AValue Graph: ISIS PHARMACEUT -- ISIS1$11.50
Apr 10, 2014Ford Investor Services, Inc.N/AIndustry Value Graph: ENTA , IDIX , ITMN , ISIS , MYGN , ORXE -- DRUGS3$34.50
Apr 10, 2014Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ISIS PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20

View All Reports for ISIS ...